Security key
07373V105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 109,387,261
- Total 13F value
- $3,753,444,539
- Share change
- +736,135
- Put/Call ratio
- 33%
- SEC-reported price per share
- $34.32
- Number of holders
- 276
- Value change
- +$51,477,491
- Number of buys
- 149
- Number of sells
- 107
- Shares outstanding
- 102,862,935
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
276
Top holders
10
BEAM full security history
Ownership snapshot
Full 13F holder table
Beam Therapeutics Inc. SEC filings
Beam Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BEAM - Beam Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FARALLON CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 13%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
13%
FARALLON CAPITAL MANAGEMENT, L.L.C.
10%
Farallon Capital Partners, L.P.
10%
ARK Investment Management LLC
10%
BlackRock, Inc.
7.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
3/4/5
13F
Other*, 10%+ Owner · Company
|
13%
|
$353,440,240
12,750,369 shares
|
-$28,167,623 | 31 Dec 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13D/G
13F
Company
|
10%
|
$368,308,762
10,282,210 shares
|
$0 | 30 Jun 2026 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
10%
|
$281,132,248
10,141,856 shares
|
+$4,681,243 | 31 Dec 2025 |
| ARK Investment Management LLC |
13D/G
13F
Company
|
10%
|
$366,612,757
10,234,862 shares
|
-$79,961,953 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.5%
from 13D/G
|
$202,258,769
8,487,569 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.2%
|
$144,934,824
5,228,529 shares
|
$0 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
276
Shares
109,387,261
Rows available
276
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
253
Q2 2026 holders
276
Holder diff
23
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|